Wan, Y., & Evans, R. M. (2010). Rosiglitazone activation of PPARγ suppresses fractalkine signaling. Society for Endocrinology.
Citación estilo ChicagoWan, Yihong, and Ronald M. Evans. Rosiglitazone Activation of PPARγ Suppresses Fractalkine Signaling. Society for Endocrinology, 2010.
Cita MLAWan, Yihong, and Ronald M. Evans. Rosiglitazone Activation of PPARγ Suppresses Fractalkine Signaling. Society for Endocrinology, 2010.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.